Heart Failure

Results from the CVD-REAL study seek to answer questions raised by the EMPA-REG OUTCOME study: do the effects of SGLT2 inhibitors on heart failure apply to a broad population?

The study from Sweden found a substantial benefit for men taking the class of drugs that was discovered by accident when researchers were developing a treatment for angina 2 decades ago.

Researchers have identified another high associated with marijuana use: the risk of heart failure and cerebrovascular accidents.

Except in cases of critical illness, the intensive care unit may not be the best place for patients experiencing a flare-up of heart failure or their chronic obstructive pulmonary disease or even having a heart attack.

The study found that avoiding 3 key risk factors-diabetes, obesity, and hypertension-by age 45, greatly increased the likelihood of avoiding heart failure through the end of life.

A study inspired by a patient who could not afford his heart medication shows that there was no pattern to price variability for a common regimen to treat heart failure, which could contribute to poor adherence.

A study of a pair of large databases shows a strong link between obesity and heart failure.

Patients who suffer heart attacks or flare-ups of congestive heart failure can fare worse in hospitals that are more likely to send them to the intensive care unit (ICU), according to a study published in CHEST.

Two studies presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure held in Florence, Italy, hold good news for patients with heart failure who get flu shots.

A secondary analysis of data from the TECOS trial of sitagliptin finds that the drug does not affect the risk for heart failure hospitalization or related adverse clinical outcomes in people with type 2 diabetes

A new trial from the National Institutes of Health found that a lower systolic blood pressure goal of 120 mm Hg reduces risk of cardiovascular events in geriatric populations.

One year after being hospitalized for heart failure, one-third of patients had not returned to work, according to a study presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

US and European professional societies coordinated their announcement to reduce confusion for physicians and payers.

Cancer patients who receive a particular type of chemotherapy, called doxorubicin, run a risk of sustaining severe, lasting heart damage. But until now, there was no way of knowing who would experience this serious side effect.